Synnovation Therapeutics

Synnovation Therapeutics is a precision medicine company developing small molecule therapies aimed at achieving optimal pharmacology for highly validated disease targets. Synnovation Therapeutics is committed to discovering and developing first-in-class treatments to improve the lives of cancer patients. With deep expertise in cancer biology and a world-class medicinal chemistry team, we are building a diverse pipeline of novel small molecule targeted therapies. Our mission is to efficiently advance these drugs into clinical trials with the goal of transforming cancer care through patient-centered precision medicine.